Skip to main content
HLB PANAGENE Co., LTD. logo

HLB PANAGENE Co., LTD. - Investor Relations & Filings

Listed IPO Aug 2000
Ticker · 046210 ISIN · KR7046210001 KO Professional, scientific and technical activities
Open in API
Filings indexed 279 across all filing types
Latest filing 2026-06-30 Major Shareholding Noti…
Country KR South Korea
Listing KO 046210 · 1 venue

About HLB PANAGENE Co., LTD.

https://www.hlbpanagene.com/

HLB PANAGENE is a molecular diagnostics company specializing in proprietary Peptide Nucleic Acid (PNA) technology. The company develops, manufactures, and supplies a range of in vitro diagnostic (IVD) products for personalized medicine, with a focus on oncology and infectious diseases. Its portfolio includes diagnostic solutions for various cancers, such as lung, colorectal, and thyroid, by detecting key genetic mutations. The company also offers real-time PCR-based kits for infectious agents like HPV and STIs. Leveraging its PNA platform for high accuracy and rapid analysis, HLB PANAGENE provides PNA materials and diagnostic kits to a global market. Through its subsidiary, the company is expanding its capabilities into immunodiagnostics and point-of-care testing.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition of shares by a major shareholder (HLB Co., Ltd.) and its special related parties. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks changes in significant ownership levels.
2026-06-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주특정증권등소유상황보고서), which is a standard regulatory filing in South Korea (DART system) used to disclose insider trading activities. It details the specific share transactions (buy/sell) by a director (Jang In Keun) of HLB Panagene. This falls under the 'Director's Dealing' category as it reports personal share transactions by a company executive.
2026-06-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주특정증권등소유상황보고서). This is a standard regulatory filing in South Korea (DART system) used by corporate insiders to disclose their personal share transactions. Based on the provided definitions, this falls under 'Director's Dealing' (DIRS), which covers reports of personal share transactions by company directors and executives.
2026-06-30 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의대량보유상황보고서), which is a regulatory filing required under the Capital Markets Act in South Korea when an entity or individual acquires a significant stake (typically 5% or more) in a company. This document details the shareholding changes, the purpose of the holding (management influence), and the specific transactions (market purchases) by the reporting entity and its special related parties. It does not fit into financial reporting categories like 10-K or IR, nor is it a simple announcement of a report. It is a specific regulatory disclosure regarding major shareholding thresholds.
2026-06-18 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주특정증권등소유상황보고서), which is a standard regulatory filing in South Korea (DART system) used to disclose insider trading activities. It details the specific share transactions (purchases) made by a director (Jang In Keun) of HLB Panagene. This falls under the 'Director's Dealing' category as it reports personal share transactions by a company executive.
2026-06-18 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주특정증권등소유상황보고서', which translates to 'Report on Ownership of Specific Securities by Executives and Major Shareholders'. It details the share transactions (purchases) made by an executive (Park Gi Woong) of HLB Panagene. This type of filing is a standard regulatory requirement for insider trading disclosures, which falls under the 'Director's Dealing' category.
2026-06-18 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.